Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago Wellness Today.
Press releases published on August 21, 2025
King Faisal Specialist Hospital Realiza Quase 300 mil Consultas Virtuais em 2024
RIADE, Arábia Saudita, Aug. 21, 2025 (GLOBE NEWSWIRE) -- O King Faisal Specialist Hospital and Research Centre (KFSHRC) realizou 293.381 consultas clínicas virtuais em 2024, um aumento de 58,2% em relação ao ano anterior. O crescimento destaca como a …
Apella Launches Scheduling Optimization, Becoming the First Ambient AI OR Platform to Unify Real-Time Management, Capacity Planning, and Performance Improvement
SAN FRANCISCO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Apella, a health technology company, today announced the launch of Apella Horizon, building out its real-time AI platform to include proactive scheduling and capacity optimization for surgical teams. With …
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The Company is on track to dose the first participant in its …
U.S. Oral Surgery Management Named to Inc. 5000 List of America’s Fastest Growing Companies
IRVING, Texas, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Inc. has named U.S. Oral Surgery Management (USOSM) to the 2025 Inc. 5000, an annual list that ranks the fastest growing private companies in the U.S., according to revenue growth over the last three years. …
InnoCare Announces First Patient Dosed in the Registrational Trial of BCL2 Inhibitor Mesutoclax for Treatment of BTKi-treated MCL Patients in China
BEIJING, Aug. 21, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the …
KFSHRC Saves Saudi 7-Year-Old Through Cross-Border Heart Transplant with UAE Donor Organ
RIYADH, Saudi Arabia, Aug. 21, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed a life-saving heart transplant on a 7-year-old Saudi child using an organ donated by a brain-dead …
Critical Inflection Point in FSGS on the Horizon with Nephrologists Poised to Rapidly Adopt New Therapies, According to Spherix Global Insights
EXTON, PA, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The treatment landscape for focal segmental glomerulosclerosis (FSGS), a rare and often progressive kidney disease, is approaching a critical inflection point. New data from Spherix Global Insights’ seventh …
Trinity Biotech Appoints Paul Tivnan as Non-Executive Director
DUBLIN, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the appointment of Paul …
Global Knee Replacement Surgery Market to Surpass USD 16.17 Billion by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The global knee replacement surgery market, valued at US$10.86 billion in 2023, stood at US$12.00 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in …
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
OCALA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s website. In this latest CEO Corner segment, AIM Chief …
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced that its AirTouch™ N30i nasal cradle mask won two prestigious Red …
Parexel Appoints Biotech Business Head Jim Anthony to Expanded Role as Chief Commercial Officer and President, Parexel Biotech
DURHAM, N.C., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced the appointment of Jim Anthony …
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States,1 Emergent BioSolutions (NYSE: EBS) is teaming up with Voices for Awareness and Facing Fentanyl Now in …
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for atumelnant, a novel, once-daily oral adrenocorticotropic …
AMPS to Spotlight ClaimInsight at CAHP 2025, Delivering a Smarter Future for Payment Integrity in California
PHOENIX, Aug. 21, 2025 (GLOBE NEWSWIRE) -- As the California healthcare system faces unprecedented financial strain and legislative complexity, Advanced Medical Pricing Solutions (AMPS) will bring a powerful cost containment solution to center stage at the …
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference
WASHINGTON, Aug. 21, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees Pharma” or the “Company”), a pharmaceutical company focused on developing new medicines for vector-borne diseases, announced today it will …
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September: Wells …
Shriners Hospitals for Children Canada golf tournament raises $581,100 for state-of-the-art medical imaging equipment
MONTREAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The 14th annual Shriners Hospitals for Children Canada Golf Tournament, held on August 7, 2025 at Summerlea Golf and Country Club, united 252 golfers, 47 volunteers, generous sponsors, and community members to …
581 100 $ récoltés pour de l’équipement d’imagerie médicale à la fine pointe lors du Tournoi de golf annuel de l’Hôpital Shriners du Canada
MONTRÉAL, 21 août 2025 (GLOBE NEWSWIRE) -- Le 14e tournoi de golf annuel de l’Hôpital Shriners pour enfants Canada, qui s’est tenu le 7 août 2025 au Summerlea Golf and Country Club, a réuni 252 golfeurs, 47 bénévoles, de généreux commanditaires et des …
Quoin Pharmaceuticals’ NETHERTON NOW Campaign Surpasses One Million Video Views, Amplifying Global Awareness of Netherton Syndrome
ASHBURN, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that its NETHERTON NOW awareness …